Use of Selincro and Impact on Usual Practice
NCT02492581 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 700
Last updated 2018-05-14
Summary
USE-PACT is a cohort study of patients initiating Selincro® with one-year follow-up, performed using a random sample of prescribers. The aim of the study is to evaluate the use of Selincro in real-life and its impact on alcohol consumption at one year.
Conditions
- Alcohol Dependence
Interventions
- DRUG
-
Nalmefene
No intervention on the use of Selincro. The physician will prescribe Selincro following its usual practice.
Sponsors & Collaborators
-
Lundbeck France
collaborator UNKNOWN -
University of Bordeaux
lead OTHER
Principal Investigators
-
Nicholas MOORE, Professor · University of Bordeaux
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-02-29
- Primary Completion
- 2018-04-30
- Completion
- 2018-04-30
Countries
- France
Study Locations
More Related Trials
-
Sertraline Pharmacotherapy for Alcoholism Subtypes
NCT00368550 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Study on Patients With Baclofen Treatment for Alcohol-dependence in France
NCT02835365 ·Status: COMPLETED
-
Nalmefene, Baclofen and Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control Subjects
NCT03034408 ·Status: COMPLETED ·Phase: PHASE2
-
Baclofen to Prevent Agitation in Alcohol Addicted Patients in ICU
NCT02723383 ·Status: COMPLETED ·Phase: PHASE3
-
Neuroscience-Informed Treatment Development for Adolescent Alcohol Use
NCT03238300 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Nalmefene in Patients With Alcohol Dependence
NCT00811941 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of N-acetylcysteine on Alcohol and Cocaine Use Disorders: A Double-Blind Randomized Controlled Trial.
NCT03018236 ·Status: UNKNOWN ·Phase: PHASE4
-
Predicting Alcoholics' Treatment Responses to a Selective Serotonin Re-uptake Inhibitor (SSRI)
NCT00249405 ·Status: COMPLETED ·Phase: PHASE2
-
Altering Memories That Increase Risk of Relapse in Alcohol Use Disorders
NCT03732248 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1
NCT00218517 ·Status: COMPLETED ·Phase: PHASE2
-
Semaglutide for Alcohol Use Disorder
NCT05520775 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of a One-month Long Detoxification Diazepam Treatment on Early Alcohol Relapse
NCT02242955 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Sertraline in Treating Pathological Gamblers With a Diagnosis of Alcohol Dependence - 1
NCT00249431 ·Status: TERMINATED ·Phase: PHASE2
-
The Effects of Treatment With Naltrexone in Alcohol and Cannabis-dependent Patients
NCT01560013 ·Status: UNKNOWN ·Phase: NA
-
Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home
NCT02885311 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Tolerability of Baclofen for Alcohol Dependence
NCT00877734 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Semaglutide Therapy for Alcohol Reduction - Tulsa
NCT05891587 ·Status: COMPLETED ·Phase: PHASE2
-
Enhancing the Effects of Alcohol Treatment With Lamotrigine
NCT04770493 ·Status: COMPLETED ·Phase: PHASE2
-
Sertraline for Alcohol Dependence and Depression
NCT00004554 ·Status: COMPLETED ·Phase: PHASE4
-
Treating Alcohol Withdrawal With Oral Baclofen
NCT00597701 ·Status: COMPLETED ·Phase: NA
-
Effect of JNJ 31001074 on Urge to Drink in Alcohol-Dependent Adults
NCT01362699 ·Status: WITHDRAWN ·Phase: PHASE2
-
Naltrexone for Heavy Drinking in Young Adults
NCT00568958 ·Status: COMPLETED ·Phase: PHASE4
-
Semantic Networks in Alcohol Use Disorder Patients: Exploratory Study
NCT05636033 ·Status: COMPLETED
-
Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease
NCT01711125 ·Status: COMPLETED ·Phase: PHASE3
-
Medication Development in Alcoholism: Suvorexant Versus Placebo
NCT04229095 ·Status: COMPLETED ·Phase: PHASE2